These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19738091)

  • 1. Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial.
    Schnuelle P; Gottmann U; Hoeger S; Boesebeck D; Lauchart W; Weiss C; Fischereder M; Jauch KW; Heemann U; Zeier M; Hugo C; Pisarski P; Krämer BK; Lopau K; Rahmel A; Benck U; Birck R; Yard BA
    JAMA; 2009 Sep; 302(10):1067-75. PubMed ID: 19738091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor desmopressin is associated with superior graft survival after kidney transplantation.
    Benck U; Gottmann U; Hoeger S; Lammert A; Rose D; Boesebeck D; Lauchart W; Birck R; Weiss C; Krämer BK; Yard BA; Schnuelle P
    Transplantation; 2011 Dec; 92(11):1252-8. PubMed ID: 22067309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of donor pre-treatment with dopamine on survival after heart transplantation: a cohort study of heart transplant recipients nested in a randomized controlled multicenter trial.
    Benck U; Hoeger S; Brinkkoetter PT; Gottmann U; Doenmez D; Boesebeck D; Lauchart W; Gummert J; Karck M; Lehmkuhl HB; Bittner HB; Zuckermann A; Wagner F; Schulz U; Koch A; Bigdeli AK; Bara C; Hirt S; Berchtold-Herz M; Brose S; Herold U; Boehm J; Welp H; Strecker T; Doesch A; Birck R; Krämer BK; Yard BA; Schnuelle P
    J Am Coll Cardiol; 2011 Oct; 58(17):1768-77. PubMed ID: 21996389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor dopamine pretreatment and graft function after kidney transplantation.
    Ridgway D; Barrie J; Menon K
    JAMA; 2010 Jan; 303(3):230-1; author reply 231-2. PubMed ID: 20085949
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor dopamine pretreatment and graft function after kidney transplantation.
    Ball J; McAnulty G
    JAMA; 2010 Jan; 303(3):231; author reply 231-2. PubMed ID: 20085948
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of Dopamine Donor Pretreatment on Graft Survival after Kidney Transplantation: A Randomized Trial.
    Schnuelle P; Schmitt WH; Weiss C; Habicht A; Renders L; Zeier M; Drüschler F; Heller K; Pisarski P; Banas B; Krämer BK; Jung M; Lopau K; Olbricht CJ; Weihprecht H; Schenker P; De Fijter JW; Yard BA; Benck U
    Clin J Am Soc Nephrol; 2017 Mar; 12(3):493-501. PubMed ID: 28213388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor catecholamine use reduces acute allograft rejection and improves graft survival after cadaveric renal transplantation.
    Schnuelle P; Lorenz D; Mueller A; Trede M; Van Der Woude FJ
    Kidney Int; 1999 Aug; 56(2):738-46. PubMed ID: 10432416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study.
    Summers DM; Johnson RJ; Hudson A; Collett D; Watson CJ; Bradley JA
    Lancet; 2013 Mar; 381(9868):727-34. PubMed ID: 23261146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of kidney transplants from non-heart-beating deceased donors as reported to the Japan Organ Transplant Network from April 1995-December 2003: a multi-center report.
    Teraoka S; Nomoto K; Kikuchi K; Hirano T; Satomi S; Hasegawa A; Uchida K; Akiyama T; Tanaka S; Babazona T; Shindo K; Nakamura N
    Clin Transpl; 2004; ():91-102. PubMed ID: 16704141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
    Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
    Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The UNOS scientific renal transplant registry. United Network for Organ Sharing.
    Cecka JM; Terasaki PI
    Clin Transpl; 1995; ():1-18. PubMed ID: 8794251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of factors that affect outcome after transplantation of kidneys donated after cardiac death in the UK: a cohort study.
    Summers DM; Johnson RJ; Allen J; Fuggle SV; Collett D; Watson CJ; Bradley JA
    Lancet; 2010 Oct; 376(9749):1303-11. PubMed ID: 20727576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preemptive kidney transplant from deceased donors: an advantage in relation to reduced waiting list.
    Pérez-Flores I; Sánchez-Fructuoso A; Calvo N; Marques M; Anaya S; Ridao N; Rodríguez A; Barrientos A
    Transplant Proc; 2007 Sep; 39(7):2123-4. PubMed ID: 17889112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of donor pretreatment with dopamine on allogeneic kidney transplantation after prolonged cold storage in rats.
    Gottmann U; Notheisen A; Brinkkoetter PT; Yard BA; Waldherr R; Schnuelle P; van der Woude FJ; Braun C
    Transplantation; 2005 May; 79(10):1344-50. PubMed ID: 15912102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid pretreatment of organ donors to prevent postischemic renal allograft failure: a randomized, controlled trial.
    Kainz A; Wilflingseder J; Mitterbauer C; Haller M; Burghuber C; Perco P; Langer RM; Heinze G; Oberbauer R
    Ann Intern Med; 2010 Aug; 153(4):222-30. PubMed ID: 20713790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of recipient and donor nonimmunologic factors on the outcome of deceased donor kidney transplantation.
    Shaheen MF; Shaheen FA; Attar B; Elamin K; Al Hayyan H; Al Sayyari A
    Transplant Proc; 2010; 42(1):273-6. PubMed ID: 20172328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor Dopamine Does Not Affect Liver Graft Survival: Evidence of Safety From a Randomized Controlled Trial.
    Benck U; Jung M; Krüger B; Grimm A; Weiss C; Yard BA; Lehner F; Kiessling A; Fischer L; Gallinat A; Kleespies A; Lorf T; Sucher R; Mönch C; Scherer MN; Rahmel A; Schemmer P; Krämer BK; Schnuelle P
    Liver Transpl; 2018 Oct; 24(10):1336-1345. PubMed ID: 30102825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remote Ischemic Conditioning on Recipients of Deceased Renal Transplants Does Not Improve Early Graft Function: A Multicenter Randomized, Controlled Clinical Trial.
    Krogstrup NV; Oltean M; Nieuwenhuijs-Moeke GJ; Dor FJ; Møldrup U; Krag SP; Bibby BM; Birn H; Jespersen B
    Am J Transplant; 2017 Apr; 17(4):1042-1049. PubMed ID: 27696662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction therapy with autologous mesenchymal stem cells in living-related kidney transplants: a randomized controlled trial.
    Tan J; Wu W; Xu X; Liao L; Zheng F; Messinger S; Sun X; Chen J; Yang S; Cai J; Gao X; Pileggi A; Ricordi C
    JAMA; 2012 Mar; 307(11):1169-77. PubMed ID: 22436957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.